D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
TNGX holding history
Tango Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TNGX overviewAll 13F holders of TNGXFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −1,025,553−100.0% | Sold out | Holders |
| Q4 2025 | 1,025,553 | $9.09M | <0.1% | +595,174+138.3% | Added | Holders |
| Q3 2025 | 430,379 | $3.62M | <0.1% | +430,379 | New | Holders |
| Q2 2025 | 0 | $0 | 0.0% | −68,269−100.0% | Sold out | Holders |
| Q1 2025 | 68,269 | $93.5K | <0.1% | −46,558−40.5% | Reduced | Holders |
| Q4 2024 | 114,827 | $354.8K | <0.1% | +114,827 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −15,413−100.0% | Sold out | Holders |
| Q4 2023 | 15,413 | $152.6K | <0.1% | +15,413 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −30,404−100.0% | Sold out | Holders |
| Q4 2022 | 30,404 | $220.4K | <0.1% | −74,487−71.0% | Reduced | Holders |
| Q3 2022 | 104,891 | $380.0K | <0.1% | −72,525−40.9% | Reduced | Holders |
| Q2 2022 | 177,416 | $804.0K | <0.1% | +177,416 | New | Holders |